
Ivaclor 5mg Tablet
Marketer
Rafflesia Life Sciences Pvt Ltd
Salt Composition
Ivabradine (5mg)
Overview Ivaclor 5mg Tablet
Ivaclor 5mg tablets treat angina pectoris (chest pain stemming from heart conditions) and chronic congestive heart failure. It enhances cardiac efficiency by reducing heart rate, thus easing chest pain and lowering hospital readmission rates in heart failure patients. Dosage varies based on the condition being treated. As treatment for angina or heart failure is typically lifelong, cessation requires physician consultation. Administer with food at the same time daily. Overdosage may cause pronounced bradycardia, fatigue, and shortness of breath; seek immediate medical help if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious adverse events like syncope and significant cardiac rhythm changes necessitate prompt medical attention. Refrain from driving until the drug's effects are known. Contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, severely low blood pressure, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Primary Ingredients of Ivaclor 5mg Tablet
No information provided. Therefore, no rephrasing is possible.
Uses of Ivaclor 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivaclor 5mg Tablet:
Consume this medication according to your physician's prescribed dosage and regimen. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ivaclor 5mg tablets should be administered with a meal.
Common Side effects of Ivaclor 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivaclor 5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ivaclor 5mg tablets should be administered with a meal.
How Ivaclor 5mg Tablet works:
Cardioquin 5mg tablets decrease heart rate, thereby lessening the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivaclor 5mg Tablet may pose unknown risks. A physician's advice is recommended.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Ivaclor 5mg tablets. Research in both animals and pregnant women has revealed considerable risks to the fetus, necessitating consultation with a physician before use.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Ivaclor 5mg tablets. Available evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivaclor 5mg Tablets, a potential side effect. These tablets can induce transient visual disturbances, primarily phosphenes. Night driving should be approached cautiously, considering the possibility of such light flashes.
KidneyCAUTION
Patients with severe kidney impairment should use Ivaclor 5mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. Data on Ivaclor 5mg tablet use in patients with severe renal dysfunction is limited.
LiverCAUTION
Patients with liver impairment should use Ivaclor 5mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Ivaclor 5mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ivaclor 5mg Tablet :
Omit any missed Ivaclor 5mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ivaclor 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Action Category | Sodium channel blockers targeting the sinoatrial node |
